With this weak auto sales numbers, on Thursday, the Nifty auto index made an intraday low of 6,783 and at 14:18 hours, Nifty Auto index was trading at 6,806.05, down by 42.30 points. Looking at the stock movements of the automakers, the stock of Maruti Suzuki gained nearly 2 per cent whereas Ashok Leyland declined by nearly 4 per cent.

India's manufacturing activity strengthened in the month of July, on the back of a quicker upturn in factory orders. Manufacturing performance surged to 52.5 in July from 52.1 in June.

The markets on August 01, 2019 opened gap down. BSE Sensex is trading at 36738.67, down by 742.45 points and the Nifty is trading at 10892.85, down by 192.55 points. 

Tata Consultancy Services has launched the ADD (Advanced Drug Development) size feasibility platform which provides life sciences companies with a single, integrated platform that digitises the site selection and activation processes, and facilitates data-driven decision-making while assessing site feasibility for multi-site clinical trials.

Many of us may have a retirement account with PFRDA. So investing Rs. 50,000 in NPS is enough to fund your retirement needs? Let’s figure it out.

Generally, D/E should be less than one as it lends financial stability. But there are capital intensive industries like infra, capital goods wherein D/E ratio remains at a higher level compared with the companies that operate in the FMCG and IT space which are like cash-generating machines.

Specialty pharmaceutical company, Unichem Laboratories informed the bourses that United States Food and Drug Administration (USFDA) has conducted a routine GMP surveillance at company’s Goa formulation facility. The company had submitted ANDAs from this facility.

India-based subsidiary of Dr. Reddy's, Aurigene has entered an exclusive collaboration agreement with the US-based oncology-focused biotech company Exelixis, Inc.

Overall volumes in futures & options currently stand at 2,27,94,937 contracts with a turnover of Rs. 15,25,426.99 crore.

Overall volumes in futures & options currently stand at 2,27,94,937 contracts with a turnover of Rs. 15,25,426.99 crore.